ARTICLE | Clinical News
ARRY-797: Phase Ib data
July 13, 2009 7:00 AM UTC
Top-line data from a double-blind, placebo-controlled, dose-escalation, U.S. Phase Ib trial in 28 stable RA patients receiving methotrexate showed that 200 mg of ARRY-797 inhibited C-reactive protein...